Replies to post #188786 on Anavex Life Sciences Corp (AVXL)

[hnbadger1]

Thanks so much Brich, I was waiting all weekend for that!!!

[nidan7500]

My personal favorite, Major publication will publish data from the Phase 2A trail instead of presenting it at a scientific conf.

Any thoughts/comments on which Major Pub and when? Thanks for your great work.

[Investor2014]

Thank you for these and the sets of notes from our other two posters, much appreciated.

My personal favorite, Major publication will publish data from the Phase 2A trail instead of presenting it at a scientific conf.

Mine too which I hope soon will leave no questions dangling and these two:

No need to have FDA / USA arm for Alz trial. Only needed if getting enough patients is an issue.

There is no magic switch from P2B to a P3. It is one trial. I get the feeling from his answer that they continue to keep a low profile on what they are doing with labeling it a P2b/3. He stated one trial and after this trial design they are done.

Although still leaves us in dark on many details of the trial e.g. doses and how are they going about titration and switching from 2b to 3.

We'll just have to remain intrigued I guess.

[bas2020]

Thanks, brich, much appreciated!

Were there any additional comments about the MTA with Biogen and why it's dead? Not that I have any concerns, just curious.

Thanks, again!

[raja48185]

Thanks to you and others who have given us the update from the meeting.

Hopefully the preferred Blank Check has been approved by a wide margin.

[baltimorebullet]

" No need to have FDA / USA arm for Alz trial. Only needed if getting enough patients is an issue."

If this referencing requirements or lack thereof for approval in the U.S.?

BB

[plexrec]

Thanks brich---excellent reporting !!!!!!!

[BostonSportsNut]

Thank you, your efforts are greatly appreciated by all of us.

[falconer66a]

Yes! Anavex, Lay Out The Long-term Findings.

Major publication will publish data from the Phase 2A trail instead of presenting it at a scientific conf.

Try to find in a “major publication” extensive data showing that the authors’ ideas and projections were in error. Doesn’t happen. Scientists don’t take time to put together data-backed arguments or papers that show that they, personally, were in error.

Not gonna happen with a new, “major publication” from Anavex, either. Simply, Anavex has significant new data sets that confirm the various efficacies and safety of Anavex 2-73 in real people with Alzheimer’s — now, over an extended multi-year period.

And, really better to present the information in a journal article; as opposed to a presentation at some distant conference somewhere with a limited number of attendees. With formal publication, the whole world sees the information.

Eager to see the paper.

[plexrec]

" Major publication will publish data from the Phase 2A "--any thoughts when we may see this publication ???